Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
VHH-Fcs 1B-3F-2A
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
VHH-Fcs 3F-1B-2A
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
Naringenin
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/20/2020
1-Benzyl-3-[[3-[3-[4-[4-(hydroxymethyl)phenyl]-6-[(4-methyl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,3-dioxan-2-yl]phenyl]phenyl]methyl]urea
Potential treatment - theoretical effect Experimental Antiviral Oct/20/2020
N-[3-[4-[4-(Hydroxymethyl)phenyl]-6-[[2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]methyl]-1,3-dioxan-2-yl]phenyl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Oct/20/2020
Leronlimab
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/20/2020
Tretinoin
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Dihydroergotamine
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Dabigatran etexilate
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Lumefantrine
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Pentagastrin
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Aclarubicin
Potential treatment - theoretical effect Experimental Antiviral Oct/19/2020
Faldaprevir
Potential treatment - theoretical effect Experimental Antiviral Oct/19/2020
Emodin
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/19/2020
Chrysin
Potential treatment - theoretical effect Natural product Antiviral Oct/19/2020
Anisotine
Potential treatment - theoretical effect Natural product Antiviral Oct/19/2020
Nicotine
Potential treatment - theoretical effect Natural product Antiviral Oct/17/2020
Caffeine
Potential treatment - theoretical effect Natural product Antiviral Oct/17/2020
Gedunin
Potential treatment - theoretical effect Natural product Antiviral Oct/16/2020
EpiVacCorona
Approved (Russia) Experimental Vaccine Oct/15/2020